We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Inpeco

Inpeco is a global leader in automation systems for clinical laboratories and designs cutting-edge solutions for both... read more Featured Products: More products

Download Mobile App




Next-Generation Total Lab Automation Solution Boosts Performance and Productivity

By LabMedica International staff writers
Posted on 20 May 2025

A new total lab automation system premiering in Europe is expected to set new benchmarks in flexibility, user experience, and performance. More...

FlexLab X, the next-generation automation system from Inpeco (Novazzano, Switzerland), has made its European debut after being unveiled at the 2025 EuroMedLab held in Brussels, Belgium. Designed to meet the needs of laboratories, FlexLab X aims to streamline workflows to the maximum – for enhanced clinical, operational, and financial outcomes. FlexLab X is a uniquely open automation system allowing labs to freely combine the analyzers of their choice from various vendors – for premium-quality results. With 12 specialties and 30 analyzers connected to date, labs can freely combine the best-of-breed analyzers from various vendors, for optimal patient outcomes. Currently, connections are available for clinical chemistry, immunoassay, hematology, ESR and HbA1c, urinalysis, molecular biology, allergy, plasma proteins, coagulation, blood screening, and FOB. The number of new analyzer connections supporting a wide range of clinical specialties is steadily growing to keep labs in touch with the future. Additionally, FlexLab X is flexible and scalable by design, thanks to standardized components that facilitate space-saving layouts tailored to specific needs and simplify future upgrades.

Designed to increase laboratory efficiency, enhance quality, and reduce cost, FlexLab X modules deliver maximum performance, while the DMX software (Data Management FlexLab X) guarantees intelligent tube routing with full sample traceability and easy performance monitoring using KPI dashboards. Harnessing the power of continuous automation monitoring, using KPI dashboards and customizable reports, DMX software helps labs optimize their clinical, operational, and financial performance. Combined, they ensure rapid and consistent turnaround times at all volume levels, as well as a best-in-class user experience. FlexLab X offers a wide range of high performing pre- and post-analytical modules to build the automation dream – be it on one single floor, or connecting several floors. They are easy to use, quiet and reliable, and feature compact dimensions to make the best use of precious lab space.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
mRNA Extraction Kits
TurboCapture mRNA Kits
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.